Curis | CRIS - Umsatzkosten





Umsatzkosten Veränderung Datum
Alaunos Therapeutics USD 0 18K 2024-09
Amgen USD 1.79B 128M 2025-12
AstraZeneca USD 3.27B 471M 2025-12
Bayer EUR 4.5B 194M 2025-12
Bristol-Myers Squibb USD 4.92B 657M 2025-12
CSL USD 3.87B 2.08B 2025-12
Curis USD 314K 9.96M 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Exelixis USD 26.48M 7.91M 2025-12
Gilead Sciences USD 1.62B 50M 2025-12
GlaxoSmithKline GBP 2.61B 377M 2025-12
Incyte USD 121.18M 22.18M 2025-12
Merck USD 3.32B 531M 2025-12
Novartis USD 3.54B 3M 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Sanofi EUR 4.29B 421M 2025-12
Takeda JPY 401.15B 184.07B 2025-12
TG Therapeutics USD 38.14M 10.05M 2025-12
Verastem USD 2.89M 2.88M 2025-12
Xoma 116K 112.7K 2024-06